Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0312546 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Bengt Wahlin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Hydroxychloroquine, Glycated Hemoglobin, Arthritis, Rheumatoid, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hydroxychloroquine (HCQ) exerts a large reduction of cardiovascular risk in patients with inflammatory diseases, but the mechanisms are not fully known. The aim of this study was to study potential mechanisms for this.
Methods
This interventional study (EudraCT 2014-005418-45) in 30 patients (23 with rheumatoid arthritis, 7 with systemic lupus erythematosus) investigates the effects of HCQ on cardiovascular risk factors and arterial stiffness in patients with inflammatory disease. Blood lipids, blood pressure, blood glucose, glycated haemoglobin (HbA1c) and arterial stiffness was assessed at initiation, after four weeks of treatment and after eight weeks of treatment with 200 mg HCQ daily.
Results
After four weeks of treatment with HCQ, total cholesterol had decreased from 5.4 mmol/L to 5.1 mmol/L (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden.
ORCID-Profile: Bengt Wahlin
Zitieren
APA
Wahlin, B., Braune, A., Jönsson, E., Wållberg-Jonsson, S., & Bengtsson, C. (2024). Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus. PLOS ONE. https://doi.org/10.1371/journal.pone.0312546
Vancouver
Wahlin B, Braune A, Jönsson E, Wållberg-Jonsson S, Bengtsson C. Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus. PLOS ONE. 2024. doi:10.1371/journal.pone.0312546
BibTeX
@article{Wahlin2024,
author = {Wahlin, Bengt and Braune, Antje and Jönsson, Elias and Wållberg-Jonsson, Solveig and Bengtsson, Christine},
title = {Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0312546}
}
EUVIMED